Loading...

Avivagen Inc.

VIVXFPNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Avivagen Inc. (VIVXF) Company Profile & Overview

Explore Avivagen Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Avivagen Inc. (VIVXF) Company Profile & Overview

Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. G. F. Kym Anthony

Contact Information

100 Sussex Drive, Ottawa, ON, K1A 0R6

Company Facts

13 Employees
IPO DateMay 2, 2013
CountryCA
Actively Trading

Frequently Asked Questions